<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font28">the </span>
   <span class="font19">[]. </span>
   <span class="font18">with </span>
   <span class="font17">CMV </span>
   <span class="font16">EBV </span>
   <span class="font15">liver </span>
   <span class="font15">infection </span>
   <span class="font14">for </span>
   <span class="font14">virus </span>
   <span class="font14">patients </span>
   <span class="font14">are </span>
   <span class="font14">disease </span>
   <span class="font13">hepatitis </span>
   <span class="font13">The </span>
   <span class="font13">may </span>
   <span class="font12">from </span>
   <span class="font12">viral </span>
   <span class="font12">immune </span>
   <span class="font12">that </span>
   <span class="font12">cells </span>
   <span class="font12">acute </span>
   <span class="font12">associated </span>
   <span class="font12">antiviral </span>
   <span class="font12">transplant </span>
   <span class="font12">{background </span>
   <span class="font11">organ </span>
   <span class="font11">clinical </span>
   <span class="font11">these </span>
   <span class="font11">after </span>
   <span class="font11">primary </span>
   <span class="font11">viruses </span>
   <span class="font11">cytomegalovirus </span>
   <span class="font11">recipients </span>
   <span class="font11">treatment </span>
   <span class="font11">severe </span>
   <span class="font11">chronic </span>
   <span class="font11">margin </span>
   <span class="font11">risk </span>
   <span class="font11">Epstein-Barr </span>
   <span class="font11">can </span>
   <span class="font11">cell </span>
   <span class="font11">{border-style </span>
   <span class="font11">has </span>
   <span class="font11">immunocompetent </span>
   <span class="font11">Liver </span>
   <span class="font11">during </span>
   <span class="font11">not </span>
   <span class="font11">px;} </span>
   <span class="font11">therapy </span>
   <span class="font11">which </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">also </span>
   <span class="font11">herpes </span>
   <span class="font11">human </span>
   <span class="font11">increased </span>
   <span class="font11">mild </span>
   <span class="font11">reactivation </span>
   <span class="font11">virus, </span>
   <span class="font11">DNA </span>
   <span class="font11">PTLD </span>
   <span class="font11">been </span>
   <span class="font11">have </span>
   <span class="font11">infections </span>
   <span class="font11">was </span>
   <span class="font10">cause </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">latent </span>
   <span class="font10">transplantation </span>
   <span class="font10">diagnosis </span>
   <span class="font10">infection, </span>
   <span class="font10">lymphoproliferative </span>
   <span class="font10">other </span>
   <span class="font10">than </span>
   <span class="font10">EBV-specific </span>
   <span class="font10">HSV </span>
   <span class="font10">development </span>
   <span class="font10">ganciclovir </span>
   <span class="font10">patients, </span>
   <span class="font10">system </span>
   <span class="font10">who </span>
   <span class="font10">common </span>
   <span class="font10">hepatitis, </span>
   <span class="font10">immunity </span>
   <span class="font10">include </span>
   <span class="font10">inflammatory </span>
   <span class="font10">replication </span>
   <span class="font10">review </span>
   <span class="font10">solid </span>
   <span class="font10">usually </span>
   <span class="font10">were </span>
   <span class="font10">This </span>
   <span class="font10">only </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">Infection </span>
   <span class="font10">allograft </span>
   <span class="font10">cells, </span>
   <span class="font10">early </span>
   <span class="font10">failure </span>
   <span class="font10">fulminant </span>
   <span class="font10">hepatotropic </span>
   <span class="font10">including </span>
   <span class="font10">innate </span>
   <span class="font10">lead </span>
   <span class="font10">manifestations </span>
   <span class="font10">mortality </span>
   <span class="font10">most </span>
   <span class="font10">role </span>
   <span class="font10">CTLs </span>
   <span class="font10">EBV-associated </span>
   <span class="font10">HCV </span>
   <span class="font10">against </span>
   <span class="font10">antibodies </span>
   <span class="font10">blood </span>
   <span class="font10">but </span>
   <span class="font10">cases </span>
   <span class="font10">classic </span>
   <span class="font10">considered </span>
   <span class="font10">control </span>
   <span class="font10">detected </span>
   <span class="font10">develop </span>
   <span class="font10">effective </span>
   <span class="font10">expression </span>
   <span class="font10">hepatic </span>
   <span class="font10">observed </span>
   <span class="font10">oral </span>
   <span class="font10">preemptive </span>
   <span class="font10">proteins </span>
   <span class="font10">px; </span>
   <span class="font10">several </span>
   <span class="font10">should </span>
   <span class="font10">simplex </span>
   <span class="font10">such </span>
   <span class="font10">{font-family </span>
   <span class="font10">Infect </span>
   <span class="font10">Rare </span>
   <span class="font10">[], </span>
   <span class="font10">active </span>
   <span class="font10">adaptive </span>
   <span class="font10">autoimmune </span>
   <span class="font10">complications </span>
   <span class="font10">detection </span>
   <span class="font10">disease. </span>
   <span class="font10">elevation </span>
   <span class="font10">following </span>
   <span class="font10">font-size </span>
   <span class="font10">genome </span>
   <span class="font10">had </span>
   <span class="font10">higher </span>
   <span class="font10">incidence </span>
   <span class="font10">individuals </span>
   <span class="font10">injury </span>
   <span class="font10">its </span>
   <span class="font10">latency </span>
   <span class="font10">lytic </span>
   <span class="font10">majority </span>
   <span class="font10">more </span>
   <span class="font10">necrosis </span>
   <span class="font10">occur </span>
   <span class="font10">response </span>
   <span class="font10">responses </span>
   <span class="font10">some </span>
   <span class="font10">syndrome </span>
   <span class="font10">through </span>
   <span class="font10">transient </span>
   <span class="font10">transplantation. </span>
   <span class="font10">treated </span>
   <span class="font10">use </span>
   <span class="font10">via </span>
   <span class="font10">Dis </span>
   <span class="font10">Early </span>
   <span class="font10">Ganciclovir </span>
   <span class="font10">However, </span>
   <span class="font10">Patients </span>
   <span class="font10">T-cell </span>
   <span class="font10">These </span>
   <span class="font10">Virus </span>
   <span class="font10">While </span>
   <span class="font10">acyclovir </span>
   <span class="font10">adults </span>
   <span class="font10">aminotransferases </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">bile </span>
   <span class="font10">biopsy </span>
   <span class="font10">cases, </span>
   <span class="font10">donor </span>
   <span class="font10">double; </span>
   <span class="font10">duct </span>
   <span class="font10">fever </span>
   <span class="font10">host </span>
   <span class="font10">hosts </span>
   <span class="font10">infected </span>
   <span class="font10">infection. </span>
   <span class="font10">infectious </span>
   <span class="font10">late </span>
   <span class="font10">levels </span>
   <span class="font10">post-transplant </span>
   <span class="font10">present </span>
   <span class="font10">presentation </span>
   <span class="font10">prevention </span>
   <span class="font10">promote </span>
   <span class="font10">ranges </span>
   <span class="font10">reduction </span>
   <span class="font10">report </span>
   <span class="font10">reported </span>
   <span class="font10">site </span>
   <span class="font10">suggested </span>
   <span class="font10">transplantation, </span>
   <span class="font10">.). </span>
   <span class="font10">B-cell </span>
   <span class="font10">D/R− </span>
   <span class="font10">EBV-infected </span>
   <span class="font10">Epstein–Barr </span>
   <span class="font10">IL-, </span>
   <span class="font10">PCR </span>
   <span class="font10">Several </span>
   <span class="font10">Transplant./j.-...x </span>
   <span class="font10">Treatment </span>
   <span class="font10">Valganciclovir </span>
   <span class="font10">Viral </span>
   <span class="font10">ability </span>
   <span class="font10">affected </span>
   <span class="font10">agents </span>
   <span class="font10">antigen </span>
   <span class="font10">antigens </span>
   <span class="font10">any </span>
   <span class="font10">based </span>
   <span class="font10">between </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">bowel </span>
   <span class="font10">case </span>
   <span class="font10">cellular </span>
   <span class="font10">colitis </span>
   <span class="font10">course </span>
   <span class="font10">damage </span>
   <span class="font10">different </span>
   <span class="font10">directed </span>
   <span class="font10">disease, </span>
   <span class="font10">diseases </span>
   <span class="font10">end </span>
   <span class="font10">fatal </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">healthy </span>
   <span class="font10">hepatitis. </span>
   <span class="font10">hepatocytes </span>
   <span class="font10">high </span>
   <span class="font10">immune-competent </span>
   <span class="font10">immunity, </span>
   <span class="font10">inclusions </span>
   <span class="font10">infections, </span>
   <span class="font10">inhibits </span>
   <span class="font10">into </span>
   <span class="font10">involvement </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">memory </span>
   <span class="font10">patients. </span>
   <span class="font10">possible </span>
   <span class="font10">promotes </span>
   <span class="font10">range </span>
   <span class="font10">rapid </span>
   <span class="font10">recipients, </span>
   <span class="font10">rejection </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">strategies </span>
   <span class="font10">therapy. </span>
   <span class="font10">there </span>
   <span class="font10">this </span>
   <span class="font10">transplantation: </span>
   <span class="font10">type </span>
   <span class="font10">used </span>
   <span class="font10">valganciclovir </span>
   <span class="font10">varicella </span>
   <span class="font10">viruses, </span>
   <span class="font10">within </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(blood </span>
   <span class="font10">CD() </span>
   <span class="font10">Chronic </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dis./ </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">HBV </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">Herpes </span>
   <span class="font10">IFN-γ </span>
   <span class="font10">IgM </span>
   <span class="font10">Med </span>
   <span class="font10">Medicine, </span>
   <span class="font10">More </span>
   <span class="font10">Primary </span>
   <span class="font10">TLR </span>
   <span class="font10">TNF-α </span>
   <span class="font10">Table </span>
   <span class="font10">affecting </span>
   <span class="font10">analysis </span>
   <span class="font10">apoptosis </span>
   <span class="font10">bold </span>
   <span class="font10">cell-mediated </span>
   <span class="font10">cells. </span>
   <span class="font10">central </span>
   <span class="font10">combination </span>
   <span class="font10">commonly </span>
   <span class="font10">compared </span>
   <span class="font10">courier; </span>
   <span class="font10">cycle </span>
   <span class="font10">degree </span>
   <span class="font10">described </span>
   <span class="font10">direct </span>
   <span class="font10">disorder </span>
   <span class="font10">does </span>
   <span class="font10">drugs </span>
   <span class="font10">due </span>
   <span class="font10">effects </span>
   <span class="font10">either </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">establish </span>
   <span class="font10">expressed </span>
   <span class="font10">form </span>
   <span class="font10">gene </span>
   <span class="font10">genes </span>
   <span class="font10">graft </span>
   <span class="font10">granulomatous </span>
   <span class="font10">hemorrhagic </span>
   <span class="font10">hepatitis: </span>
   <span class="font10">however, </span>
   <span class="font10">important </span>
   <span class="font10">increase </span>
   <span class="font10">indistinguishable </span>
   <span class="font10">induced </span>
   <span class="font10">intranuclear </span>
   <span class="font10">involved </span>
   <span class="font10">lesions </span>
   <span class="font10">life-threatening </span>
   <span class="font10">lifelong </span>
   <span class="font10">loss </span>
   <span class="font10">low </span>
   <span class="font10">lower </span>
   <span class="font10">lymphoma, </span>
   <span class="font10">major </span>
   <span class="font10">monitored </span>
   <span class="font10">mononucleosis </span>
   <span class="font10">months </span>
   <span class="font10">nervous </span>
   <span class="font10">occurs </span>
   <span class="font10">often </span>
   <span class="font10">outcome </span>
   <span class="font10">outcomes </span>
   <span class="font10">phases </span>
   <span class="font10">play </span>
   <span class="font10">potential </span>
   <span class="font10">prophylaxis, </span>
   <span class="font10">pt;} </span>
   <span class="font10">reaction </span>
   <span class="font10">received </span>
   <span class="font10">recent </span>
   <span class="font10">recently </span>
   <span class="font10">recommended </span>
   <span class="font10">rejection, </span>
   <span class="font10">rejection. </span>
   <span class="font10">resulting </span>
   <span class="font10">retinitis, </span>
   <span class="font10">specific </span>
   <span class="font10">spectrum </span>
   <span class="font10">symptomatic </span>
   <span class="font10">their </span>
   <span class="font10">therapy, </span>
   <span class="font10">thrombocytopenia, </span>
   <span class="font10">tissue) </span>
   <span class="font10">tract </span>
   <span class="font10">viremia </span>
   <span class="font10">virus-specific </span>
   <span class="font10">vs. </span>
   <span class="font10">well </span>
   <span class="font10">young </span>
   <span class="font10">zoster </span>
  </p>
 </body>
</html>
